Larimar Therapeutics (NASDAQ:LRMR) reported its Q4 earnings results on Thursday, March 14, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Larimar Therapeutics missed estimated earnings by -20.0%, reporting an EPS of $-0.3 versus an estimate of $-0.25.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 14.000000000000002% increase in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Larimar Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.